Both the Department of Justice (DOJ) and the Recovery Audit Contractors (RAC) are focusing investigations on Medicare billing for implantable cardiac defibrillator (ICD) surgery. The reimbursement rate for ICD surgery is one of the higher dollar Medicare Severity Diagnosis Related Groupings (MS-DRG). The DOJ’s investigation is focusing on both medical necessity and MS-DRG coding validation issues, while the RACs are currently only conducting MS-DRG validation reviews. According to the CMS national coverage determination (NCD), Medicare pays for ICD implantation for eight specific conditions. However, there are many circumstantial limitations to coverage in these conditions that often lead to CMS not covering the implantation. For example, the beneficiary must not have had an acute myocardial infarction within 40 days prior to surgery. If a hospital being investigated by the DOJ performed the implantation despite this condition, the DOJ is requiring them to justify why they thought the surgery was medically necessary. The DOJ is sending out document production requests, requesting all documents related to ICD implantation coding, billing, payment, reimbursement, payment denials and ICD-related appeals by all payers. Additionally, RACs are conducting coding and validation reviews of MS-DRGs related to ICD surgery. When conducting validation reviews, the RACs are looking at the beneficiary’s medical record, specifically the diagnostic and procedural information and discharge status, to determine whether the ICD surgery MS-DRG code listed is supported by the proper documentation.Consider yourself warned, criminals.
Remember that malpractice litigation we were worried about? What were we thinking?
Those were the good ol' days.
-Wes
Reference: “Justice Dept. Investigates Hospitals for Cardiac Billing in New Spin on RAC Risk.” Report on Medicare Compliance Vol. 19, No. 15. 26 Apr. 2010; 1, 5.
Read up on Dr. Midei in Maryland. One doctor found to have placed unnecessary stents in >500 patients in 2+ years and more to come. No complications so he escaped peer review.
ReplyDeleteJust another way to increase costs within the system, not to mention cause even more problems with physician recruitment and retention.
ReplyDeleteNothing like attacking a problem by attacking the good along with the bad. Cha-ching, cha-ching, cha-ching.
If you really want to get investigated, start prescribing buprenorphine, the opiate replacement therapy that is licensed to be prescribed in a physician office. The DEA has decided to audit the charts of every single physician with a waiver to prescribe, because some small percentage of buprenorphine is being diverted. In the meantime, large amounts of Oxycontin and Lortab are going astray, and they just look the other way.
ReplyDeleteWes,
ReplyDeleteI have weighed in with a post to "break the tie" between you and Dr. John M. on this matter: http://tinyurl.com/22lxxet
Rich
Rich-
ReplyDeleteAnother erudite take.